Literature DB >> 315271

Induction, inhibition, and biological properties of aryl hydrocarbon hydroxylase in a stable human B-lymphocyte cell line, RPMI-1788.

H J Freedman, N B Parker, A J Marinello, H L Gurtoo, J Minowada.   

Abstract

Aryl hydrocarbon hydroxylase was induced in the absence of mitogens by several compounds in a stable, human B-lymphocyte cell line (RPMI-1788). Over the dose ranges tested and on molar basis the inducers, in decreasing order of potency, were 2,3,7,8-tetrachlorodibenzo-p-dioxin, dibenz(a,h)-anthracene, 3-methylcholanthrene, benzo(a)pyrene, and 1,2-benzanthracene. Potential inducers which, paradoxically, diminished basal aryl hydrocarbon hydroxylase, included 7,12-dimethylbenzanthracene, 2,5-diphenyloxazole, and chyrsene. Induction under optimal culture conditions ensured maximal activities 3- to 4 fold above basal aryl hydrocarbon hydroxylase. The characteristics of the induced [dibenz(a,h)anthracene] and basal enzymes were found virtually identical. Both had similar pH curves (optima at 8.25) and inhibitor specificity (alpha- and beta-naphthoflavones, metyrapone, and 2-diethylaminoethyl-2,2-diphenylvalerate in decreasing potency). Induced and basal enzymes exhibited similar half-lives (41, 46 hr), apparent activation energies (16.7, 16.6 kcal/mol), temperature optima (37-38, 38-39 degrees), temperature-dependence of denaturation (range, 42-50 degrees), and apparent Km's with benzo(a)pyrene (1.8, 0.8 microM). The small difference in the apparent Km was related to enzyme concentration in the incubation rather than to the quality of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 315271

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  1 in total

1.  Effects of dideoxyinosine and dideoxycytidine on the intracellular phosphorylation of zidovudine in human mononuclear cells.

Authors:  G J Veal; M J Wild; M G Barry; D J Back
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.